Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE: 002262)
Health Care · Pharmaceuticals · CN
CN¥22.73
+7.42% today · -18.2% 1Y
Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE: 002262) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.44B and employs 6,003 people.
Over the last twelve months the share price has lost 18.2%, trading between 17.96 and 27.90.
Tweenvest scores Jiangsu Nhwa Pharmaceutical Co., LTD across four factors: quality 84/100, value 53/100, growth 61/100, dividend 36/100. Its strongest factor is quality.
002262 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.44B
- Revenue (TTM)
- $900.85M
- P/E
- 20.85
- EPS
- 1.09
- Dividend yield
- 1.76%
- Beta (5Y)
- -0.30
- 52-week high
- CN¥27.90
- 52-week low
- CN¥17.96
- Avg volume (3M)
- —
- Shares outstanding
- 1.02B
- Employees
- 6,003
- Next earnings
- —
About Jiangsu Nhwa Pharmaceutical Co., LTD
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
- ISIN
- CNE100000CG8
- Founded
- 1978
- Listed since
- Jul 15, 2008
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hubei Jumpcan Pharmaceutical Co., Ltd.SHSE: 600566 | $3.52B | CN¥25.63 | +3.06% |
| Wockhardt LimitedNSEI: WOCKPHARMA | $3.52B | Rs2,083.90 | -8.02% |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSHSE: 600329 | $3.51B | CN¥35.32 | +2.08% |
| Amylyx Pharmaceuticals, Inc.NasdaqGS: AMLX | $3.44B | $27.01 | -1.53% |
| China Resources Pharmaceutical Group LimitedSEHK: 3320 | $3.44B | HK$4.30 | -1.26% |
| Regencell Bioscience Holdings LimitedNasdaqCM: RGC | $3.38B | $7.00 | +2.64% |
| Laboratorios Farmaceuticos Rovi, S.A.BME: ROVI | $3.38B | €58.60 | -0.68% |
| Santen Pharmaceutical Co., Ltd.TSE: 4536 | $3.35B | ¥1,645.50 | -5.89% |
Figures last refreshed Oct 4, 2026.